SCHEMBL4632629

SCHEMBL4632629

O=C(Nc1n[nH]c2sc(C(=O)O)cc12)c1ccc(CN2CCSC2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.42
BCR P11274 1/20 0.42
KDR P35968 2/20 0.41
FLT3 P36888 6/20 0.38
KIT P10721 1/20 0.38
CDC7 O00311 5/20 0.38
DAPK3 O43293 5/20 0.38
PAK4 O96013 5/20 0.38
CSNK1A1 P48729 5/20 0.38
CLK2 P49760 5/20 0.38
PRKX P51817 5/20 0.38
CDK5 Q00535 5/20 0.38
DYRK1A Q13627 5/20 0.38
MELK Q14680 5/20 0.38
HIPK2 Q9H2X6 5/20 0.38
STK17A Q9UEE5 5/20 0.38
MAP4K5 Q9Y4K4 5/20 0.38
AURKA O14965 4/20 0.38
ROCK2 O75116 4/20 0.38
MAP4K4 O95819 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3085794 0.89 ABL1 (0.50) ABL1BCRKDRFLT3KIT
SCHEMBL3104562 0.89 ABL1 (0.52) ABL1BCRKDRFLT3KIT
SCHEMBL3085713 0.88 ABL1 (0.53) ABL1BCRKDRFLT3KIT
SCHEMBL3106720 0.88 ABL1 (0.53) ABL1BCRKDRFLT3KIT
SCHEMBL4633593 0.87 HDAC1 (0.48) ABL1BCRKDRFLT3KIT
SCHEMBL3102260 0.87 KDR (0.53) ABL1BCRKDRFLT3KIT
SCHEMBL742370 0.86 ABL1 (0.61) ABL1BCRKDRFLT3KIT
SCHEMBL3102293 0.86 HIF1A (0.53) FLT3AURKAALDH1A1RAB9AMAPK1
SCHEMBL4776009 0.85 KIT (0.45) ABL1BCRKDRFLT3KIT
SCHEMBL4632529 0.84 ABL1 (0.49) ABL1BCRKDRFLT3KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1711177-B1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS PFIZER ITALIA SRL (IT) 2008-05-28 EP claimed
US-20050187209-A1 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2005-08-25 US claimed
US-8481584-B2 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2013-07-09 US disclosed
US-20120165311-A1 1H-THIENO[2,3-C]PYRAZOLE DERIVATIVES USEFUL AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-06-28 US disclosed
EP-1711177-B1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS PFIZER ITALIA SRL (IT) 2008-05-28 EP disclosed
EP-1711177-A1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS Pfizer Italia S.r.l. (IT) 2006-10-18 EP disclosed
US-20050187209-A1 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2005-08-25 US disclosed
WO-2005074922-A1 1H-THIENO[2,3-c]PYRAZOLE DERIVATIVES USEFUL AS KINASE INHIBITORS PFIZER ITALIA S.R.L. (IT) 2005-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165311-A1 1H-THIENO[2,3-C]PYRAZOLE DERIVATIVES USEFUL AS KINASE INHIBITORS MAP3K19, MAP3K1, MAP3K3 ABL1 151/4885BCR 942/4885KDR 1029/4885
US-20050187209-A1 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors MAP3K19, MAP3K1, MAP3K3 ABL1 149/4885BCR 907/4885KDR 1040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.